易聯眾(300096.SZ)中標國家醫保局軟件採購項目兩個包
格隆匯4月8日丨易聯眾(300096.SZ)公佈,近日,公司收到中國機械進出口(集團)有限公司發來的兩份《政府採購項目中標通知書》,確定公司為國家醫療保障局醫療保障信息平台建設工程業務應用軟件採購項目(以下簡稱“國家醫保局軟件採購項目”)第5包和第8包的中標人,中標金額合計人民幣368.00萬元,佔公司2018年度經審計營業收入的0.50%。
國家醫保局軟件採購項目是國家醫保局組建以來首次系統性招標,目的是為國家醫保局搭建全國醫保信息平台,推動醫保改革。公司長期專注於新醫改下的醫保信息化領域,是三明醫改總集成商和福建省全省醫保信息化總承建商。本次中標,公司將參與國家醫保局的5個應用子系統建設,包括公共服務子系統、信用評價管理子系統、基礎信息管理子系統、醫保業務基礎子系統、應用支撐平台子系統,涉及醫保核心業務、互聯網應用、大數據應用領域,標誌着公司在醫保信息化領域的經驗和核心競爭力得到鞏固和進一步認同,對公司業務戰略升級具有里程碑式的重要意義。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.